GlassScriptPhysician profile
Morgan Bleininger
NPI 1558937342
$2,333.49
in general payments reported to CMS, 2019-2025
16 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $394 · 2023: $842 · 2024: $707 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,898 · Gift: $40.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,898.21 |
| Gift | $40.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $808.34 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $501.41 | 2022-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $350.28 | 2022-2025 | Tremfya, Stelara, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $127.02 | 2022-2024 | Entyvio |
| Ardelyx, INC. | $105.06 | 2023-2025 | Ibsrela |
| Braintree Laboratories, INC. | $77.77 | 2023 | Sutab, Suflave |
| Genzyme Corporation | $71.17 | 2022-2024 | |
| Phathom Pharmaceuticals, INC. | $55.24 | 2024-2025 | Voquezna |
| Madrigal Pharmaceuticals | $50.14 | 2025 | Rezdiffra |
| Lucid Diagnostics INC. | $35.90 | 2024 | |
| Aimmune Therapeutics, INC. | $33.73 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $32.22 | 2024 | Dupixent |
| Merck Sharp & Dohme LLC | $26.81 | 2022-2023 | Dificid |
| Ferring Pharmaceuticals INC. | $23.70 | 2024 | Clenpiq |
| Celgene Corporation | $20.96 | 2023 | Zeposia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.74 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Bleininger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.